Renaissance Technologies (RenTech)'s OLMA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 25,067 shares of Olema Pharmaceuticals, Inc. (OLMA) worth $626,675, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in OLMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 247,332 shares. Largest reduction occurred in Q1 2024, reducing 173,611 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Olema Pharmaceuticals (OLMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Olema Pharmaceuticals (OLMA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -65,033 | Reduce 72.18% | 25,067 | $25.00 |
| Q3 2025 | +31,300 | Add 53.23% | 90,100 | $9.79 |
| Q2 2025 | -5,800 | Reduce 8.98% | 58,800 | $4.26 |
| Q1 2025 | -92,700 | Reduce 58.93% | 64,600 | $3.76 |
| Q4 2024 | +127,900 | Add 435.03% | 157,300 | $5.83 |
| Q3 2024 | -23,800 | Reduce 44.74% | 29,400 | $11.94 |
| Q2 2024 | +53,200 | New Buy | 53,200 | $10.82 |
| Q1 2024 | -173,611 | Sold Out | 0 | $0.00 |
| Q4 2023 | -136,889 | Reduce 44.09% | 173,611 | $14.03 |
| Q3 2023 | +17,600 | Add 6.01% | 310,500 | $12.35 |
| Q2 2023 | +35,700 | Add 13.88% | 292,900 | $0.01 |
| Q1 2023 | -9,000 | Reduce 3.38% | 257,200 | $0.00 |
| Q4 2022 | -114,300 | Reduce 30.04% | 266,200 | $0.00 |
| Q3 2022 | +94,366 | Add 32.98% | 380,500 | $2.76 |
| Q2 2022 | +38,802 | Add 15.69% | 286,134 | $4.07 |
| Q1 2022 | +247,332 | New Buy | 247,332 | $4.26 |
| Q4 2021 | -97,900 | Sold Out | 0 | $0.00 |
| Q3 2021 | +97,900 | New Buy | 97,900 | $27.56 |
Renaissance Technologies (RenTech)'s Olema Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased Olema Pharmaceuticals, Inc. (OLMA) in Q3 2021, acquiring 97,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Olema Pharmaceuticals, Inc. (OLMA) for 18 quarters since Q3 2021.
Renaissance Technologies (RenTech)'s largest addition to Olema Pharmaceuticals, Inc. (OLMA) was in Q1 2022, adding 247,332 shares worth $1.05 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 25,067 shares of Olema Pharmaceuticals, Inc. (OLMA), valued at approximately $626,675.
As of the Q4 2025 filing, Olema Pharmaceuticals, Inc. (OLMA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Olema Pharmaceuticals, Inc. (OLMA) was 380,500 shares, as reported at the end of Q3 2022.